Based on the provided data and recent market activity, here's a comprehensive analysis of whether CMCSA is overvalued:
Technical Analysis
Valuation Assessment
CMCSA is currently trading at reasonable valuation levels with a P/E ratio of 11.82x, significantly below its historical 5-year average of around 20x.
Recent Performance and Fundamentals
The stock has shown strong fundamental improvements with net income increasing substantially from $5.37B in 2022 to $15.39B in 2023, while maintaining stable revenue growth.
Market Sentiment
Recent analyst consensus shows a "Moderate Buy" rating with 17 Strong Buy and 11 Hold ratings, suggesting the stock is not overvalued at current levels.
Conclusion
Based on the combination of strong earnings growth, reasonable valuation metrics, and positive analyst sentiment, CMCSA appears fairly valued to slightly undervalued at current price levels.